Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical
Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical
Recruiting · NCT05296889 · Registry updated 2026-08-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical | Back Injuries, Neoplasms by Site, bone disorder, bone fracture, central nervous system cancer, central nervous system disorder, injury, intervertebral disk degenerative disorder, musculoskeletal system disorder, neoplasm, nervous system disorder, spinal cord disorder, spinal cord neoplasm, spinal fracture, spinal injury, vertebral column disorder | Recruiting | Not stated | 2026-08-03 | NCT05296889 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aesculap AG | 30 |
| Raylytic GmbH | 5 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Berufsgenossenschaft Klinikum Bergmannstrost Halle / Saale | Halle | Germany | 1 |
| Krankenhaus Ludmillenstift Meppen | Meppen | Germany | 1 |
| Schön Klinik Hamburg Eilbek | Hamburg | Germany | 1 |
| Städtisches Klinikum Dresden | Dresden | Germany | 1 |